Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß.

Chu IM, Lai WC, Aprelikova O, El Touny LH, Kouros-Mehr H, Green JE.

PLoS One. 2013;8(4):e61125. doi: 10.1371/journal.pone.0061125. Epub 2013 Apr 8.

2.

Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma.

Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G.

Clin Cancer Res. 2013 Jan 1;19(1):42-9. doi: 10.1158/1078-0432.CCR-12-2606. Epub 2012 Nov 7.

3.

Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility.

Aprelikova O, Palla J, Hibler B, Yu X, Greer YE, Yi M, Stephens R, Maxwell GL, Jazaeri A, Risinger JI, Rubin JS, Niederhuber J.

Oncogene. 2013 Jul 4;32(27):3246-53. doi: 10.1038/onc.2012.351. Epub 2012 Aug 13.

4.

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.

Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE.

Breast Cancer Res. 2012 Jul 19;14(4):R109. doi: 10.1186/bcr3230.

5.

miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE.

BMC Med Genomics. 2011 Nov 23;4:79. doi: 10.1186/1755-8794-4-79.

6.

MicroRNA regulation in cancer-associated fibroblasts.

Aprelikova O, Green JE.

Cancer Immunol Immunother. 2012 Feb;61(2):231-7. doi: 10.1007/s00262-011-1139-7. Epub 2011 Nov 16. Review.

7.

Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis.

Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM.

J Cancer. 2011;2:271-9. Epub 2011 May 12.

8.

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.

Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J.

Cell Cycle. 2010 Nov 1;9(21):4387-98. Epub 2010 Nov 17.

9.

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Aprelikova O, Pandolfi S, Tackett S, Ferreira M, Salnikow K, Ward Y, Risinger JI, Barrett JC, Niederhuber J.

Cancer Res. 2009 Jan 15;69(2):616-24. doi: 10.1158/0008-5472.CAN-08-0811.

10.

Regulation of hypoxia-inducible genes by ETS1 transcription factor.

Salnikow K, Aprelikova O, Ivanov S, Tackett S, Kaczmarek M, Karaczyn A, Yee H, Kasprzak KS, Niederhuber J.

Carcinogenesis. 2008 Aug;29(8):1493-9. doi: 10.1093/carcin/bgn088. Epub 2008 Apr 1.

11.

BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.

Evans TA, Raina AK, Delacourte A, Aprelikova O, Lee HG, Zhu X, Perry G, Smith MA.

Int J Med Sci. 2007 May 12;4(3):140-5.

12.

BRCA1-mediated repression of select X chromosome genes.

Jazaeri AA, Chandramouli GV, Aprelikova O, Nuber UA, Sotiriou C, Liu ET, Ropers HH, Yee CJ, Boyd J, Barrett JC.

J Transl Med. 2004 Sep 21;2(1):32.

13.

Universal Reference RNA as a standard for microarray experiments.

Novoradovskaya N, Whitfield ML, Basehore LS, Novoradovsky A, Pesich R, Usary J, Karaca M, Wong WK, Aprelikova O, Fero M, Perou CM, Botstein D, Braman J.

BMC Genomics. 2004 Mar 9;5(1):20.

14.

Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system.

Kohn KW, Riss J, Aprelikova O, Weinstein JN, Pommier Y, Barrett JC.

Mol Biol Cell. 2004 Jul;15(7):3042-52. Epub 2004 Apr 23.

15.

BRCA1-associated growth arrest is RB-dependent.

Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET.

Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11866-71.

16.

The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.

Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K.

J Exp Med. 1993 Dec 1;178(6):2077-88.

17.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk